Girls in the first birth cohort to be offered and receive the HPV vaccine showed a lower degree of dysplasia which may eventually lead to cervical cancer than a birth cohort from 1983. This is the conclusion of a new study conducted by researchers at the University of Copenhagen, who have been the first to study the vaccine’s effect on the general population.Watch Now
More than two dozen ADCs are currently being used in the clinic to treat diseases like Hodgkin's lymphoma and breast cancer, and researchers are developing many more. But it's taken decades to find the right combination of drug, antibody target and linker, and then make sure the right amount of ADC hits the tumor.
Near-infrared photoimmunotherapy uses an antibody–photoabsorber conjugate that binds to cancer cells. When near-infrared light is applied, the cells swell and then burst, causing the cancer cell to die.Watch Now
Discover how scientists are harnessing the body's own immune system to fight cancer, and how they are using quantitative pathology solutions from PerkinElmer to better understanding the interactions between the immune system and cancer, and to identify biomarkers for translational research.Watch Now
Sir Ian Wilmut discusses Dolly, the first clone of an adult mammal.Watch Now
Blood tests that fish for either tumour DNA or cancer cells in patient blood samples are showing great promise. This type of blood analysis is helping Cancer Research UK scientists and doctors better understand the biology of cancer from its earliest origins to when it spreads around the body.Watch Now
27th International Conference on Nanomedicine and Nanomaterials
Oct 18 - Oct 19, 2018